Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018883
Filing Date
2024-05-13
Accepted
2024-05-13 16:11:01
Documents
43
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 511767
2 ex31-1.htm EX-31.1 12224
3 ex31-2.htm EX-31.2 12121
4 ex32-1.htm EX-32.1 7044
5 ex32-2.htm EX-32.2 7245
  Complete submission text file 0001493152-24-018883.txt   2960643

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE afjk-20240331.xsd EX-101.SCH 21989
7 XBRL CALCULATION FILE afjk-20240331_cal.xml EX-101.CAL 21167
8 XBRL DEFINITION FILE afjk-20240331_def.xml EX-101.DEF 118745
9 XBRL LABEL FILE afjk-20240331_lab.xml EX-101.LAB 169210
10 XBRL PRESENTATION FILE afjk-20240331_pre.xml EX-101.PRE 151087
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 397223
Mailing Address 10 EAST 53RD STREET SUITE 3001 NEW YORK NY 10022
Business Address 10 EAST 53RD STREET SUITE 3001 NEW YORK NY 10022 34 678 035200
Aimei Health Technology Co., Ltd. (Filer) CIK: 0001979005 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41880 | Film No.: 24939165
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)